title: Breast cancer angiogenesis: therapy target and prognostic factor.
authors.affiliation: ICRF Molecular Oncology Laboratories, John Radcliffe Hospital, Headington, Oxford, U.K.
authors.forename: A L
authors.initials: AL
authors.lastname: Harris
authors.forename: S
authors.initials: S
authors.lastname: Fox
authors.forename: R
authors.initials: R
authors.lastname: Leek
authors.forename: H
authors.initials: H
authors.lastname: Zhang
authors.forename: P
authors.initials: P
authors.lastname: Scott
authors.forename: R
authors.initials: R
authors.lastname: Bicknell
authors.forename: K
authors.initials: K
authors.lastname: Gatter
mesh_terms: D043925:Angiogenesis Inducing Agents / Q000037:antagonists & inhibitors; D001943:Breast Neoplasms / Q000098:blood supply* / Q000628:therapy; D005260:Female; D006801:Humans; D009389:Neovascularization, Pathologic / Q000209:etiology / Q000628:therapy; D011379:Prognosis
chemical_list: D043925:Angiogenesis Inducing Agents